DiaMedica Therapeutics to Participate in the B. Riley Securities’ Neuroscience Conference

Rhea-AI Summary

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) announced that President and CEO Rick Pauls will present at the B. Riley Neuroscience Investor Conference on April 29th at 11:30am ET. The company will also be available for one-on-one meetings at the event, with investors encouraged to schedule these through B. Riley. The recorded presentation will be accessible on DiaMedica’s website starting April 29th.

DiaMedica focuses on developing treatments for neurological disorders and kidney diseases, aiming to enhance patient quality of life.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the Rick Pauls, President and CEO, will deliver a corporate presentation at B. Riley’s Neuroscience Investor Conference on Thursday, April 29^th at 11:30am ET. DiaMedica will be available for one-on-one meetings at this conference and investors may request a one-on-one meeting through B. Riley.

The recorded presentation will be available on the Investors section of the Company’s website at https://www.diamedica.com/investors/events-presentations beginning Thursday, April 29^th.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases. To learn more about DiaMedica, visit www.diamedica.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210422005062/en/

FAQ

When is DiaMedica's presentation at the B. Riley Neuroscience Investor Conference?

DiaMedica's presentation is scheduled for April 29th at 11:30am ET.

Who will present on behalf of DiaMedica at the conference?

DiaMedica's President and CEO, Rick Pauls, will deliver the presentation.

How can investors request a one-on-one meeting with DiaMedica at the conference?

Investors can request a one-on-one meeting through B. Riley.

Where can I find the recorded presentation by DiaMedica?

The recorded presentation will be available on DiaMedica's website starting April 29th.

What is the focus of DiaMedica Therapeutics Inc.?

DiaMedica is focused on developing novel treatments for neurological disorders and chronic kidney diseases.